medical treatments

Stock Market

Novavax stock shedding a quarter of its value as vaccine maker’s business in ‘substantial doubt’

[ad_1] Novavax Inc. shares shares sank in the extended session Tuesday after the biotech drug maker posted more than double…

Read More »
Stock Market

Novavax: ‘Substantial Doubt’ Around Ability to Continue

[ad_1] Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this…

Read More »
Stock Market

Moderna Earnings Hit by Falling Covid Vaccine Sales

[ad_1] Moderna stock fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings…

Read More »
Stock Market

Crispr Therapeutics Stock Gains on Hope for Sickle-Cell Gene Therapy

[ad_1] An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said,…

Read More »
Stock Market

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

[ad_1] Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped…

Read More »
Stock Market

Moderna Stock Is Upgraded on Growth Opportunities Not Related to Covid

[ad_1] Moderna was rising Monday after an analyst at Jefferies upgraded the stock citing confidence in the vaccine maker’s growth…

Read More »
Stock Market

BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline

[ad_1] Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA…

Read More »
Stock Market

Moderna Soared on Good News About Cancer Vaccine. Why the Stock Was Downgraded.

[ad_1] Moderna stock jumped by double digits Tuesday on positive news about the company’s cancer vaccine, but Chardan Capital Markets…

Read More »
Stock Market

As Demand for Mental-Health Care Booms, Investors See Opportunities

[ad_1] Psychiatrists and psychologists once ran their own practices. Now the local therapist office could be controlled by a buyout…

Read More »
Back to top button
Close